Clinical findings in patients with cardiac troponin T elevation and end-stage renal disease without acute coronary syndrome

Clinical, echocardiographic, and carotid ultrasound parameters were compared according to the level of cardiac tropopin T (cTnT) (cTnT <0.04 vs ≥0.04 μg/L; cTnT <0.1 vs ≥0.1 μg/L) in patients with end-stage renal disease without acute coronary syndrome. Left atrial size, left ventricular mass index, the ratio of transmitral early left ventricular filling velocity to early diastolic Doppler tissue imaging velocity of the mitral annulus, and the prevalence of left ventricular dysfunction and diabetes mellitus were higher in the groups with cTnT ≥0.04 and ≥0.1 μg/L. Diabetes was an independent correlate of cTnT elevation of ≥0.04 and ≥0.1 μg/L. Left ventricular mass index and left atrial size were independent predictors of cTnT elevations of ≥0.04 and ≥0.1 μg/L, respectively.